These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3274859)

  • 1. Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.
    Ettenger R; Cho S; Marik J; von Lilien T; Fine RN
    Transplant Proc; 1987 Feb; 19(1 Pt 1):740-2. PubMed ID: 3274859
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
    Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
    Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplant outcome of desensitized recipients after donor-specific transfusion.
    Okazaki H; Takahashi H; Oguma S; Jimbo M; Ishizaki M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):750-2. PubMed ID: 3274863
    [No Abstract]   [Full Text] [Related]  

  • 5. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic immunologic pretransplantation monitoring in clinical kidney allotransplantation].
    Sochnev AM; Burshteĭn AM; Shif BA; Samoshenkova LP
    Vestn Akad Med Nauk SSSR; 1988; (7):63-70. PubMed ID: 2973191
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HLA antibodies in recipients of renal allografts.
    Suciu-Foca N; McManus P; Ho E; Reed E; Benvenisty A; Hardy M; Brensilver J; McCabe R; King DW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):754-5. PubMed ID: 2650257
    [No Abstract]   [Full Text] [Related]  

  • 8. B cell antibodies after planned transfusions.
    van den Berg-Loonen PM; Leunissen KM; Kootstra G; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):743. PubMed ID: 3274860
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the risk factors associated with donor specific blood transfusion.
    Vaidya S; Sommer BG; Pagel EA; Koegel M; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2268. PubMed ID: 3274505
    [No Abstract]   [Full Text] [Related]  

  • 10. Panel-reactive antibodies using complement-dependent cytotoxicity, flow cytometry, and ELISA in patients awaiting renal transplantation or transplanted patients: a comparative study.
    Mansour I; Messaed C; Azoury M; Klayme S; Naaman R
    Transplant Proc; 2001 Aug; 33(5):2844-7. PubMed ID: 11498183
    [No Abstract]   [Full Text] [Related]  

  • 11. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive crossmatches due to autoantibodies in living-related transplantation.
    Myrberg SJ; Connors CM; Carpenter CB; Garovoy MR
    Transplant Proc; 1979 Dec; 11(4):1954-7. PubMed ID: 394440
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved graft survival following donor-specific blood transfusions.
    Cochrum K; Hanes D; Potter D; Perkins H; Amend W; Vincenti F; Iwaki Y; Opelz G; Terasaki P; Levin B; Sampson D; Feduska N; Salvatierra O
    Transplant Proc; 1981 Sep; 13(3):1657-61. PubMed ID: 7029829
    [No Abstract]   [Full Text] [Related]  

  • 14. Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
    Schweizer R; Bow L; Generas D; Bartus S
    Transplant Proc; 1982 Jun; 14(2):374-7. PubMed ID: 6810522
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS; Suthanthiran M; Kaplan M; Evelyn M; Riggio RR; Fotino M; Schechter N; Wolf CF; Stubenbord WT; Stenzel KH
    Transplantation; 1984 Nov; 38(5):501-6. PubMed ID: 6238460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of DR antibody in patients awaiting a renal allograft.
    Brasile L; Clarke J; Cerilli J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):706-7. PubMed ID: 2650234
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
    Vaidya S
    Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusions under cyclosporine coverage before renal transplantation in children.
    Niaudet P; Bouvattier C; Gouda H; Mattlinger B; Caillat-Zucman S; Gagnadoux MF; Broyer M; Jean G
    Transplant Proc; 1995 Apr; 27(2):1723-4. PubMed ID: 7725470
    [No Abstract]   [Full Text] [Related]  

  • 20. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.